Davide Povero Selected Research

Davide Povero Research Topics

Disease

9	Inflammation (Inflammations) 01/2023 - 01/2010
8	Non-alcoholic Fatty Liver Disease 01/2023 - 10/2010
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2010
7	Fatty Liver 02/2016 - 10/2010
6	Fibrosis (Cirrhosis) 01/2023 - 10/2010
6	Hypoxia (Hypoxemia) 01/2023 - 12/2008
4	Alcoholic Fatty Liver 01/2023 - 01/2017
4	Liver Diseases (Liver Disease) 12/2022 - 01/2010
3	Obesity 01/2023 - 10/2010
3	Neoplasms (Cancer) 11/2020 - 12/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 11/2022
2	Pathologic Neovascularization 02/2016 - 10/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Cryopyrin-Associated Periodic Syndromes 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Lupus Nephritis 01/2023
1	Sclerosing Cholangitis 01/2022
1	Portal Hypertension 01/2018
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Disease Progression 01/2014
1	Insulin Resistance 10/2010

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2010
6	InflammasomesIBA 01/2023 - 01/2017
4	LipidsIBA 01/2023 - 10/2013
3	Choline (Choline Chloride)IBA 01/2023 - 01/2014
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 12/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2015
2	CDAA (Randox)IBA 01/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 02/2015 - 01/2014
2	Triglycerides (Triacylglycerol)IBA 06/2014 - 01/2014
2	nasIBA 06/2014 - 10/2010
2	Caspase 3 (Caspase-3)IBA 06/2014 - 10/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2011 - 12/2008
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	CeramidesIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	NLR ProteinsIBA 01/2023
1	GS-621763IBA 01/2023
1	Complement System Proteins (Complement)IBA 12/2022
1	Connective Tissue Growth FactorIBA 12/2022
1	Leucine (L-Leucine)FDA Link 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	Lipase (Acid Lipase)FDA Link 11/2020
1	Glutamine (L-Glutamine)FDA Link 11/2020
1	CaspasesIBA 01/2018
1	Vasoconstrictor AgentsIBA 01/2018
1	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 01/2018
1	andrographolideIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	ArginaseIBA 02/2015
1	Methionine (L-Methionine)FDA Link 06/2014
1	Transaminases (Aminotransferases)IBA 06/2014
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2014
1	Amino Acids FDA Link 01/2014
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2014
1	EicosanoidsIBA 01/2014
1	ProteomeIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014
1	Protein Kinases (Protein Kinase)IBA 06/2011
1	Phosphotransferases (Kinase)IBA 06/2011
1	Immunoglobulin G (IgG)IBA 10/2010
1	Malondialdehyde (Propanedial)IBA 10/2010
1	Blood Proteins (Serum Proteins)IBA 10/2010
1	Human Serum Albumin FDA LinkGeneric 10/2010
1	AntibodiesIBA 10/2010
1	clonidine-displacing substance (ClDS)IBA 01/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009
1	Glycogen Synthase Kinase 3 betaIBA 12/2008
1	Cadherins (E-Cadherin)IBA 12/2008
1	beta CateninIBA 12/2008

Therapy/Procedure

4	Therapeutics 01/2017 - 01/2010
3	Ligation 11/2019 - 01/2017
1	Aftercare (After-Treatment) 01/2021
1	Intravenous Injections 11/2019